RESIST-ADT (Androgen Deprivation Therapy)

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Prostate CancerPhysical Function
Interventions
BEHAVIORAL

Progressive Resistance Training Exercise

Progressive Resistance Training Exercise 2x weekly for 6 months.

BEHAVIORAL

Flexibility and Balance Exercise

Flexibility and Balance Exercise Training Exercise 2x weekly for 6 months.

Trial Locations (2)

02066

Dana-Farber Cancer Institute, Boston

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT04485767 - RESIST-ADT (Androgen Deprivation Therapy) | Biotech Hunter | Biotech Hunter